MedPath

A prospective, double-blind, randomized controlled trial of TCM syndrome differentiation combined with andis classification in the treatment of stage IV diabetic kidney disease of spleen kidney qi deficiency type

Phase 1
Not yet recruiting
Conditions
Diabetic kidney disease
Registration Number
ITMCTR2000003821
Lead Sponsor
onghua Hospital Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) The clinical diagnosis of DKD stage IV was spleen kidney qi deficiency type;
(2) Aged 18 to 75 years old;
(3) The patients were informed and signed the informed consent.

Exclusion Criteria

(1) Urinary sediment indicates active hematuria;
(2) The renal function decreased rapidly in a short time;
(3) Acute infection and acute complications of diabetes (diabetic ketoacidosis, hyperglycemia and hyperosmolarity);
(4) Severe heart, brain, liver, kidney and other organic diseases, malignant tumor and mental disease patients;
(5) Pregnant or lactating women.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glomerular filtration rate;
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath